Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > OCRL(Gene name) > Human
  • Add your favorite
  • OCRL (Gene name),
  • Inositol polyphosphate 5-phosphatase OCRL-1 (Protein name ),  OCRL_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    OCRL(INPP5F;OCRL1);
    Protein name:
    Inositol polyphosphate 5-phosphatase OCRL-1;
    Alternative:
    Lowe oculocerebrorenal syndrome protein;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with APPL1, FAM109A and FAM109B; APPL1-binding and FAM109A-binding are mutually exclusive. Interacts with clathrin heavy chain.
    Function:
    Converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate. Also converts inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate and inositol 1,3,4,5-tetrakisphosphate to inositol 1,3,4-trisphosphate. May function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes.
    Subcellular Location:
    Endosome Also found on macropinosomes.
    Protein Attributes:
    Sequence length:
    901
    Sequence:
    50:
    MEPPLPVGAQ | PLATVEGMEM | KGPLREPCAL | TLAQRNGQYE | LIIQLHEKEQ | 
    100:
    HVQDIIPINS | HFRCVQEAEE | TLLIDIASNS | GCKIRVQGDW | IRERRFEIPD | 
    150:
    EEHCLKFLSA | VLAAQKAQSQ | LLVPEQKDSS | SWYQKLDTKD | KPSVFSGLLG | 
    200:
    FEDNFSSMNL | DKKINSQNQP | TGIHREPPPP | PFSVNKMLPR | EKEASNKEQP | 
    250:
    KVTNTMRKLF | VPNTQSGQRE | GLIKHILAKR | EKEYVNIQTF | RFFVGTWNVN | 
    300:
    GQSPDSGLEP | WLNCDPNPPD | IYCIGFQELD | LSTEAFFYFE | SVKEQEWSMA | 
    350:
    VERGLHSKAK | YKKVQLVRLV | GMMLLIFARK | DQCRYIRDIA | TETVGTGIMG | 
    400:
    KMGNKGGVAV | RFVFHNTTFC | IVNSHLAAHV | EDFERRNQDY | KDICARMSFV | 
    450:
    VPNQTLPQLN | IMKHEVVIWL | GDLNYRLCMP | DANEVKSLIN | KKDLQRLLKF | 
    500:
    DQLNIQRTQK | KAFVDFNEGE | IKFIPTYKYD | SKTDRWDSSG | KCRVPAWCDR | 
    550:
    ILWRGTNVNQ | LNYRSHMELK | TSDHKPVSAL | FHIGVKVVDE | RRYRKVFEDS | 
    600:
    VRIMDRMEND | FLPSLELSRR | EFVFENVKFR | QLQKEKFQIS | NNGQVPCHFS | 
    650:
    FIPKLNDSQY | CKPWLRAEPF | EGYLEPNETV | DISLDVYVSK | DSVTILNSGE | 
    700:
    DKIEDILVLH | LDRGKDYFLT | ISGNYLPSCF | GTSLEALCRM | KRPIREVPVT | 
    750:
    KLIDLEEDSF | LEKEKSLLQM | VPLDEGASER | PLQVPKEIWL | LVDHLFKYAC | 
    800:
    HQEDLFQTPG | MQEELQQIID | CLDTSIPETI | PGSNHSVAEA | LLIFLEALPE | 
    850:
    PVICYELYQR | CLDSAYDPRI | CRQVISQLPR | CHRNVFRYLM | AFLRELLKFS | 
    900:
    EYNSVNANMI | ATLFTSLLLR | PPPNLMARQT | PSDRQRAIQF | LLGFLLGSEE | 
    901:
    D
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    Pfam:
    MIM:
    UniGene:
    SMR:
    String:
    KEGG:
    Uniprot:
     
    FOR
    ELISA Kit for Human Inositol polyphosphate 5-phosphatase OCRL-1
    ELISA Kit for Human Inositol polyphosphate 5-phosphatase OCRL-1
    ELISA Kit for Human Inositol polyphosphate 5-phosphatase OCRL-1
    CLIA Kit for Human Inositol polyphosphate 5-phosphatase OCRL-1
    CLIA Kit for Human Inositol polyphosphate 5-phosphatase OCRL-1
    CLIA Kit for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Polyclonal Antibody for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Polyclonal Antibody for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Polyclonal Antibody for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Monoclonal Antibody for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Monoclonal Antibody for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Monoclonal Antibody for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Protein for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Protein for Human Inositol polyphosphate 5-phosphatase OCRL-1
    Protein for Human Inositol polyphosphate 5-phosphatase OCRL-1

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase."
      Attree O. , Olivos I.M. , Okabe I. , Bailey L.C. , Nelson D.L. , Lewis R.A. , McInnes R.R. , Nussbaum R.L.
      Nature358:239-242(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B)
      tissue: Kidney.
    2. 2.
      Attree O. , Olivos I.M. , Okabe I. , Bailey L.C. , Nelson D.L. , Lewis R.A. , McInnes R.R. , Nussbaum R.L.
      Submitted (2001-03) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SEQUENCE REVISION TO 585
    3. 3.
      "Physical mapping and genomic structure of the Lowe syndrome gene OCRL1."
      Nussbaum R.L. , Orrison B.M. , Janne P.A. , Charnas L.R. , Chinault A.C.
      Hum. Genet.99:145-150(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];ALTERNATIVE SPLICING
      tissue: Brain.
    4. 4.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A)
      tissue: Uterus.
    5. 5.
      "The DNA sequence of the human X chromosome."
      Ross M.T. , Grafham D.V. , Coffey A.J. , Scherer S. , McLay K. , Muzny D. , Platzer M. , Howell G.R. , Burrows C. , Bird C.P. , Frankish A. , Lovell F.L. , Howe K.L. , Ashurst J.L. , Fulton R.S. , Sudbrak R. , Wen G. , Jones M.C. , more...
      Nature434:325-337(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    6. 6.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    7. 7.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B)
    8. 8.
      "Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe."
      Leahey A.-M. , Charnas L.R. , Nussbaum R.L.
      Hum. Mol. Genet.2:461-463(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 814-843
    9. 9.
      "The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase."
      Zhang X. , Jefferson A.B. , Auethavekiat V. , Majerus P.W.
      Proc. Natl. Acad. Sci. U.S.A.92:4853-4856(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION
    10. 10.
      "Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate."
      Zhang X. , Hartz P.A. , Philip E. , Racusen L.C. , Majerus P.W.
      J. Biol. Chem.273:1574-1582(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION
    11. 11.
      "Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1."
      Swan L.E. , Tomasini L. , Pirruccello M. , Lunardi J. , De Camilli P.
      Proc. Natl. Acad. Sci. U.S.A.107:3511-3516(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH APPL1; CLATHRIN; FAM109A AND FAM109B;SUBCELLULAR LOCATION;VARIANTS OCRL ASN-768 AND PRO-797
    12. 12.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    13. 13.
      "The PH domain proteins IPIP27A and B link OCRL1 to receptor recycling in the endocytic pathway."
      Noakes C.J. , Lee G. , Lowe M.
      Mol. Biol. Cell22:606-623(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH APPL1; FAM109A AND FAM109B;VARIANT OCRL ASN-768
    14. 14.
      "OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome."
      Luo N. , West C.C. , Murga-Zamalloa C.A. , Sun L. , Anderson R.M. , Wells C.D. , Weinreb R.N. , Travers J.B. , Khanna H. , Sun Y.
      Hum. Mol. Genet.21:3333-3344(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CILIA ASSEMBLY;TISSUE SPECIFICITY;SUBCELLULAR LOCATION;INTERACTION WITH RAB8A;MUTAGENESIS OF ASP-422; ASP-499 AND PHE-668
    15. 15.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CILIOGENESIS
    16. 16.
      "Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL."
      Pirruccello M. , De Camilli P.
      Trends Biochem. Sci.37:134-143(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    17. 17.
      "A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism."
      Mao Y. , Balkin D.M. , Zoncu R. , Erdmann K.S. , Tomasini L. , Hu F. , Jin M.M. , Hodsdon M.E. , De Camilli P.
      EMBO J.28:1831-1842(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 1-119;DOMAIN PH;INTERACTION WITH CLATHRIN;SUBCELLULAR LOCATION
    18. 18.
      "A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1."
      Hou X. , Hagemann N. , Schoebel S. , Blankenfeldt W. , Goody R.S. , Erdmann K.S. , Itzen A.
      EMBO J.30:1659-1670(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 540-678 IN COMPLEX WITH RAB8A
    19. 19.
      "A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway."
      Erdmann K.S. , Mao Y. , McCrea H.J. , Zoncu R. , Lee S. , Paradise S. , Modregger J. , Biemesderfer D. , Toomre D. , De Camilli P.
      Dev. Cell13:377-390(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 564-901;SUBCELLULAR LOCATION;INTERACTION WITH APPL1
    20. 20.
      "Recognition of the F&H motif by the Lowe syndrome protein OCRL."
      Pirruccello M. , Swan L.E. , Folta-Stogniew E. , De Camilli P.
      Nat. Struct. Mol. Biol.18:789-795(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 536-901 IN COMPLEX WITH FAM109A
    21. 21.
      "Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome."
      Lin T. , Orrison B.M. , Leahey A.-M. , Suchy S.F. , Bernard D.J. , Lewis R.A. , Nussbaum R.L.
      Am. J. Hum. Genet.60:1384-1388(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OCRL THR-367 DEL; GLY-451; SER-463 AND ARG-524
    22. 22.
      "Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients."
      Lin T. , Orrison B.M. , Suchy S.F. , Lewis R.A. , Nussbaum R.L.
      Mol. Genet. Metab.64:58-61(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OCRL TYR-375; GLN-500; ASP-508 AND CYS-513
    23. 23.
      "Oculocerebrorenal syndrome of Lowe: three mutations in the OCRL1 gene derived from three patients with different phenotypes."
      Kawano T. , Indo Y. , Nakazato H. , Shimadzu M. , Matsuda I.
      Am. J. Med. Genet.77:348-355(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OCRL GLN-500 AND GLN-524
    24. 24.
      "Identification of two novel mutations in the OCRL1 gene in Japanese families with Lowe syndrome."
      Kubota T. , Sakurai A. , Arakawa K. , Shimazu M. , Wakui K. , Furihata K. , Fukushima Y.
      Clin. Genet.54:199-202(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT OCRL ARG-522
    25. 25.
      "OCRL1 mutation analysis in French Lowe syndrome patients: implications for molecular diagnosis strategy and genetic counseling."
      Monnier N. , Satre V. , Lerouge E. , Berthoin F. , Lunardi J.
      Hum. Mutat.16:157-165(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OCRL GLU-357; GLU-421; ASP-424 AND TYR-498
    26. 26.
      "Carrier assessment in families with Lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination."
      Roeschinger W. , Muntau A.C. , Rudolph G. , Roscher A.A. , Kammerer S.
      Mol. Genet. Metab.69:213-222(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OCRL LYS-478-479-TYR DEL; GLN-500 AND LEU-526
    27. 27.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS DD2 CYS-318 AND CYS-479
    28. 28.
      "OCRL1 mutations in patients with Dent disease phenotype in Japan."
      Sekine T. , Nozu K. , Iyengar R. , Fu X.J. , Matsuo M. , Tanaka R. , Iijima K. , Matsui E. , Harita Y. , Inatomi J. , Igarashi T.
      Pediatr. Nephrol.22:975-980(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS DD2 CYS-318 AND TRP-493
    29. 29.
      "Magnetic resonance imaging, magnetic resonance spectroscopy, and facial dysmorphism in a case of Lowe syndrome with novel OCRL1 gene mutation."
      Yuksel A. , Karaca E. , Albayram M.S.
      J. Child Neurol.24:93-96(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT OCRL LYS-591
    30. 30.
      "From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes."
      Hichri H. , Rendu J. , Monnier N. , Coutton C. , Dorseuil O. , Poussou R.V. , Baujat G. , Blanchard A. , Nobili F. , Ranchin B. , Remesy M. , Salomon R. , Satre V. , Lunardi J.
      Hum. Mutat.32:379-388(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OCRL SER-242; THR-274; ARG-277; CYS-318; CYS-337; ILE-361; GLY-372; TYR-373; PHE-374; ARG-414; ASN-451; GLY-457; LYS-468; GLY-468; LEU-495; HIS-499; ARG-503; LYS-591; VAL-742 DEL; PRO-797; LEU-801 AND ARG-891;VARIANTS DD2 HIS-354 AND LEU-799
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2026 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter